Skip to main content
. 2023 Aug 19;78(10):2471–2480. doi: 10.1093/jac/dkad256

Figure 2.

Figure 2.

Participant disposition. AE, adverse event; FMGX, fosmanogepix; ITT, intent-to-treat; mITT, modified intent-to-treat.